CARA: Approved Prospectus


Oslo, October 21, 2021: Reference is made to the stock exchange announcements on
May 25, and July 22, where Carasent ASA (the "Company") announced that the
Company had carried out two successful private placements.

The first private placement (the "Private Placement 1") was finalized following
the acquisition of Metodika AB on May 25, 2021 where a Seller's Note of NOK
23,229,999.50 was issued to the sellers. The Seller's Note was then subsequently
used as payment for 588,235 new shares (the "New Shares 1") at NOK 39.49 per

The second private placement (the "Private Placement 2") was finalized following
a direct placement completed on July 22, 2021 towards Cardigan Holdco S.à r.l.,
a company indirectly owned by Vitruvian Investment Partnership IV, a fund
managed by Vitruvian Partners LLP (together "Vitruvian"). The Private Placement
2 covered issuance of 11,987,332 new shares (the "New Shares 2") at NOK 35.05
with a total cash consideration of NOK 420 million.

The shares issued under to Private Placement 1 and 2 combined amounts to
12,575,567 shares (the "Offer Shares"). The Offers Shares were listed on a
separate ISIN and was unlisted pending approval of a listing prospectus (the
"Prospectus") by the Norwegian Financial Supervisory Authority (the "NFSA"). The
NFSA has reviewed and approved the Company's prospectus on October 21, 2021
regarding the listing of the Offer Shares. Following the NFSA approval of the
Prospectus, the Unlisted Shares will be transferred to the Company's ordinary
ISIN and will be listed on the Oslo Stock Exchange. The Prospectus is attached
and will also be made available at (

The Prospectus will also be available at the offices of the Company. For further
information, please contact: Johan Lindqvist, Chairman +46 733 55 09 35.

Important Notices
This document is not an offer to sell or a solicitation of offers to purchase or
subscribe for shares. Copies of this document may not be sent to jurisdictions,
or distributed in or sent from jurisdictions, in which this is barred or
prohibited by law. The information contained herein shall not constitute an
offer to sell or the solicitation of an offer to buy, in any jurisdiction in
which such offer or solicitation would be unlawful prior to registration,
exemption from registration or qualification under the securities laws of any
jurisdiction. This communication may not be published, distributed or
transmitted in or into the United States, Canada, Australia, the Hong Kong
Special Administrative Region of the People's Republic of China, South Africa or
Japan and it does not constitute an offer or invitation to subscribe for or
purchase any securities in such countries or in any other jurisdiction. In
particular, the document and the information contained herein should not be
distributed or otherwise transmitted into the United States of America or to
U.S. persons (as defined in the U.S. Securities Act of 1933, as amended (the
"Securities Act")) or to publications with a general circulation in the United
States of America. This document is not an offer for sale of securities in the
United States. The securities referred to herein have not been and will not be
registered under the Securities Act, or the laws of any state, and may not be
offered or sold in the United States of America absent registration under or an
exemption from registration under Securities Act. Carasent does not intend to
register any part of the offering in the United States. There will be no public
offering of the securities in the United States of America. The information
contained herein does not constitute an offer of securities to the public in the
United Kingdom. No prospectus offering securities to the public will be
published in the United Kingdom. This document is only being distributed to and
is only directed at (i) persons who are outside the United Kingdom or (ii) to
investment professionals falling within article 19(5) of the Financial Services
and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii)
high net worth entities, and other persons to whom it may lawfully be
communicated, falling within article 49(2)(a) to (d) of the Order (all such
persons together being referred to as "relevant persons"). The securities are
only available to, and any invitation, offer or agreement to subscribe, purchase
or otherwise acquire such securities will be engaged in only with, relevant
persons. Any person who is not a relevant person should not act or rely on this
document or any of its contents. This announcement is an advertisement and does
not constitute a prospectus for the purposes of the Prospectus Regulation (EU)
2017/1129 (as amended, together with any applicable implementing measures in any
Member State, the "Prospectus Regulation"). In any EEA Member State that has
implemented the Prospectus Regulation, this communication is only addressed to
and is only directed at qualified investors in that Member State within the
meaning of the Prospectus Regulation. Investing in securities involves certain
risks. This publication may contain specific forward-looking statements, e.g.
statements including terms like "believe", "assume", "expect", "forecast",
"project", "may", "could", "might", "will" or similar expressions. Such forward
-looking statements are subject to known and unknown risks, uncertainties and
other factors which may result in a substantial divergence between the actual
results, financial situation, development or performance of Carasent and those
explicitly or implicitly presumed in these statements. Against the background of
these uncertainties, readers should not rely on forward-looking statements.
Carasent assumes no responsibility to update forward -looking statements or to
adapt them to future events or developments. This announcement is made by and,
and is the responsibility of, the Company. This information is subject to the
disclosure requirements pursuant to section 5 -12 of the Norwegian Securities
Trading Act and section 4-6 of the Oslo Rulebook II - Issuer Rules.

More Press releases